{"id":40865,"title":"Financing and Insurance (Part 12 of Phase 3 study of Vaccine Candidate for COVID-19)","title_html":"Financing and Insurance (Part 12 of Phase 3 study of Vaccine Candidate for COVID-19)","image":{"source":"https:\/\/s3.amazonaws.com\/protocols-files\/public\/6f37aae407d1c3261f56707cf7d8e3a47c4d284af7e8d2ae19cb40776fda17a7\/chxzcz36.png","placeholder":"https:\/\/s3.amazonaws.com\/protocols-files\/public\/6f37aae407d1c3261f56707cf7d8e3a47c4d284af7e8d2ae19cb40776fda17a7\/chxzcz36.png"},"doi":"dx.doi.org\/10.17504\/protocols.io.bj59kq96","doi_status":2,"uri":"financing-and-insurance-part-12-of-phase-3-study-o-bj59kq96","type_id":1,"template_id":1,"published_on":1598394566,"parent_protocols":[],"parent_collections":[],"cited_protocols":[],"version_id":0,"created_on":1598072488,"categories":null,"creator":{"name":"Chris Ockenhouse","affiliation":null,"affiliations":[],"username":"w2y26423q203","note":null,"link":null,"image":{"source":"\/img\/avatars\/014.png","placeholder":"\/img\/avatars\/014.png"},"badges":[{"id":4,"image":{"source":"\/img\/badges\/gold.svg","placeholder":"\/img\/badges\/gold.svg"},"name":"Gold power author!"}],"verified":0,"is_verified_user":false,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},"journal":null,"journal_name":null,"journal_link":null,"article_citation":null,"public":1,"has_versions":0,"link":null,"total_collections":1,"number_of_steps":0,"authors":[{"name":"Chris Ockenhouse","affiliation":"Center for Vaccine Innovation and Access, PATH (Washington D.C. and Seattle, Washington)","affiliations":[],"username":"w2y26423q203","note":null,"link":null,"image":{"source":"\/img\/avatars\/014.png","placeholder":"\/img\/avatars\/014.png"},"badges":[],"verified":1,"is_verified_user":true,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},{"name":"Chris Gast","affiliation":"Center for Vaccine Innovation and Access, PATH (Washington D.C. and Seattle, Washington)","affiliations":[],"username":"w2y26423q213","note":null,"link":null,"image":{"source":"\/img\/avatars\/005.png","placeholder":"\/img\/avatars\/005.png"},"badges":[],"verified":0,"is_verified_user":false,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},{"name":"Renee Holt","affiliation":"Center for Vaccine Innovation and Access, PATH (Washington D.C. and Seattle, Washington)","affiliations":[],"username":"w2y26423r2s2","note":null,"link":null,"image":{"source":"\/img\/avatars\/001.png","placeholder":"\/img\/avatars\/001.png"},"badges":[],"verified":0,"is_verified_user":false,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},{"name":"Jorge Flores","affiliation":"Center for Vaccine Innovation and Access, PATH (Washington D.C. and Seattle, Washington)","affiliations":[],"username":"w2y26423r2t2","note":null,"link":null,"image":{"source":"\/img\/avatars\/005.png","placeholder":"\/img\/avatars\/005.png"},"badges":[],"verified":0,"is_verified_user":false,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false}],"versions":[],"groups":[{"id":1682,"uri":"coronavirus-method-development-community","title":"Coronavirus Method Development Community","image":{"source":"https:\/\/s3.amazonaws.com\/protocols-files\/public\/7ef07ff3faeb41d8ea644f433c443c1d6f7d7c3cd480d4aebeeccb93a3f61ccf\/bzujfw26.png","placeholder":"https:\/\/s3.amazonaws.com\/protocols-files\/public\/7ef07ff3faeb41d8ea644f433c443c1d6f7d7c3cd480d4aebeeccb93a3f61ccf\/bzujfw26.png"},"tech_support":{"email":null,"phone":null,"hide_contact":0,"use_email":0,"url":null},"is_member":0,"request":{"id":1682,"uri":"coronavirus-method-development-community","title":"Coronavirus Method Development Community","image":{"source":"https:\/\/s3.amazonaws.com\/protocols-files\/public\/7ef07ff3faeb41d8ea644f433c443c1d6f7d7c3cd480d4aebeeccb93a3f61ccf\/bzujfw26.png","placeholder":"https:\/\/s3.amazonaws.com\/protocols-files\/public\/7ef07ff3faeb41d8ea644f433c443c1d6f7d7c3cd480d4aebeeccb93a3f61ccf\/bzujfw26.png"},"tech_support":{"email":null,"phone":null,"hide_contact":0,"use_email":0,"url":null},"is_member":0,"description":null,"research_interests":null,"website":null,"location":null,"affiliation":null,"status":{"is_visible":true,"access_level":0},"stats":{"files":[],"total_members":0,"total_followers":0,"total_child_groups":0,"total_parent_groups":0,"has_collaborations":0},"user_status":{"is_member":false,"is_confirmed":true,"is_invited":false,"is_owner":false,"is_admin":false,"is_following":false},"join_link":null,"token":null,"owner":{"name":" ","affiliation":null,"affiliations":[],"username":null,"note":null,"link":null,"image":{"source":null,"placeholder":null},"badges":[],"verified":0,"is_verified_user":false,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},"is_protocol_requested":0,"is_group_requested":0,"is_my":false,"is_request":false,"is_confirmed":1,"is_declined":0,"requester":{"name":" ","affiliation":null,"affiliation_url":null,"username":null,"link":null},"protocol":{"id":0,"title":"Financing and Insurance (Part 12 of Phase 3 study of Vaccine Candidate for COVID-19)","title_html":"Financing and Insurance (Part 12 of Phase 3 study of Vaccine Candidate for COVID-19)","image":{"source":null,"placeholder":null},"doi":null,"doi_status":0,"uri":"financing-and-insurance-part-12-of-phase-3-study-o-bj59kq96","type_id":1,"template_id":0,"published_on":null,"stats":{"number_of_views":0,"number_of_steps":0,"number_of_bookmarks":0,"number_of_comments":0,"number_of_exports":0,"number_of_runs":0,"number_of_votes":0,"is_voted":0},"parent_protocols":[],"parent_collections":[],"cited_protocols":[]},"created_on":1598394347,"resolve_on":0,"resolved_user":{"name":" ","affiliation":null,"affiliations":[],"username":null,"note":null,"link":null,"image":{"source":null,"placeholder":null},"badges":[],"verified":0,"is_verified_user":false,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},"shared":false}},{"id":6790,"uri":"path","title":"PATH","image":{"source":"https:\/\/www.protocols.io\/img\/group_placeholder.png","placeholder":"https:\/\/www.protocols.io\/img\/group_placeholder.png"},"tech_support":{"email":null,"phone":null,"hide_contact":0,"use_email":0,"url":null},"is_member":1,"request":{"id":6790,"uri":"path","title":"PATH","image":{"source":"https:\/\/www.protocols.io\/img\/group_placeholder.png","placeholder":"https:\/\/www.protocols.io\/img\/group_placeholder.png"},"tech_support":{"email":null,"phone":null,"hide_contact":0,"use_email":0,"url":null},"is_member":1,"description":null,"research_interests":null,"website":null,"location":null,"affiliation":null,"status":{"is_visible":true,"access_level":0},"stats":{"files":[],"total_members":0,"total_followers":0,"total_child_groups":0,"total_parent_groups":0,"has_collaborations":0},"user_status":{"is_member":true,"is_confirmed":true,"is_invited":false,"is_owner":true,"is_admin":false,"is_following":false},"join_link":null,"token":null,"owner":{"name":" ","affiliation":null,"affiliations":[],"username":null,"note":null,"link":null,"image":{"source":null,"placeholder":null},"badges":[],"verified":0,"is_verified_user":false,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},"is_protocol_requested":0,"is_group_requested":0,"is_my":false,"is_request":false,"is_confirmed":1,"is_declined":0,"requester":{"name":" ","affiliation":null,"affiliation_url":null,"username":null,"link":null},"protocol":{"id":0,"title":"Financing and Insurance (Part 12 of Phase 3 study of Vaccine Candidate for COVID-19)","title_html":"Financing and Insurance (Part 12 of Phase 3 study of Vaccine Candidate for COVID-19)","image":{"source":null,"placeholder":null},"doi":null,"doi_status":0,"uri":"financing-and-insurance-part-12-of-phase-3-study-o-bj59kq96","type_id":1,"template_id":0,"published_on":null,"stats":{"number_of_views":0,"number_of_steps":0,"number_of_bookmarks":0,"number_of_comments":0,"number_of_exports":0,"number_of_runs":0,"number_of_votes":0,"is_voted":0},"parent_protocols":[],"parent_collections":[],"cited_protocols":[]},"created_on":1598394567,"resolve_on":0,"resolved_user":{"name":" ","affiliation":null,"affiliations":[],"username":null,"note":null,"link":null,"image":{"source":null,"placeholder":null},"badges":[],"verified":0,"is_verified_user":false,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},"shared":false}}],"is_owner":1,"has_subprotocols":0,"is_subprotocol":0,"is_bookmarked":0,"can_claim_authorship":0,"can_accept_authorship":0,"can_be_copied":1,"can_remove_fork":1,"fork_id":null,"url":"https:\/\/www.protocols.io\/view\/financing-and-insurance-part-12-of-phase-3-study-o-bj59kq96","forks_count":{"private":0,"public":0},"access":{"can_view":1,"can_remove":0,"can_add":0,"can_edit":0,"can_publish":0,"can_get_doi":0,"can_share":1,"can_move":1,"can_move_outside":1,"can_transfer":1,"can_download":1,"is_locked":0},"guid":"B32DF036093541FA937B330270BF1E15","state_version_id":10,"steps":[],"document":null,"materials":[],"description":"<div class = \"text-blocks\"><div class = \"text-block\"><span>This is Part 12 of \"Phase 3 randomized, double-blinded, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of <\/span><span style = \"font-weight:bold;\">Vaccine Candidate<\/span><span> against COVID-19 in adults > 18 years of age\"<\/span><\/div><div class = \"text-block\">This generic Phase 3 protocol was developed by the PATH team with support of the Bill and Melinda Gates Foundation. The aim of the collection is to share recommended best practices in designing and implementing a Phase 3 study of a COVID-19 vaccine candidate. As Phase 3 trials of different Vaccine Candidates  proceed around the world, following the same protocols will ensure consistency and comparability of the Phase 3 trial results.<\/div><div class = \"text-block\"><span style = \"font-weight:bold;\">Please note<\/span><span> that this is an evolving document, to be versioned and updated, based on community feedback and new data.<\/span><\/div><\/div>","changed_on":1598394566}